,Date,Study,Study Link,Journal,Study Type,Sample Size,Age,Sample obtained,Asymptomatic,Specific Sampled Viral load correlated to postive test,Excerpt,Added on
0,2020-03-23,Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30196-1/fulltext,The Lancet Infectious disease,Observational Cohort study,23.0,mean: 62;  range: 37–75,Serum,N,Y,COVID-19 highest viral load correlated with increased likelihood of positive test,4/26/2020
1,2020-03-23,Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30196-1/fulltext,The Lancet Infectious disease,Observational Cohort study,23.0,mean: 62;  range: 37–75,Urine,N,N,COVID-19 highest viral load correlated with increased likelihood of positive test,4/26/2020
2,2020-03-23,Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30196-1/fulltext,The Lancet Infectious disease,Observational Cohort study,23.0,mean: 62;  range: 37–75,Posterior oropharyngeal saliva,N,Y,COVID-19 highest viral load correlated with increased likelihood of positive test,4/26/2020
3,2020-03-23,Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30196-1/fulltext,The Lancet Infectious disease,Observational Cohort study,23.0,mean: 62;  range: 37–75,Rectal,N,N,COVID-19 highest viral load correlated with increased likelihood of positive test,4/26/2020
4,2020-03-27,Clinical and virological data of the first cases of COVID-19 in Europe,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30200-0/fulltext,The Lancet Infectious disease,Observational Cohort study,5.0,range: 30-80,Nasopharyngeal,N,Y,High viral loads in upper respiratory tract samples are suggestive of potentially high risk of transmissibility during the very first days of symptoms,4/26/2020
5,2020-03-27,Clinical and virological data of the first cases of COVID-19 in Europe,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30200-0/fulltext,The Lancet Infectious disease,Observational Cohort study,5.0,range: 30-80,Plasma,N,Y,High viral loads in upper respiratory tract samples are suggestive of potentially high risk of transmissibility during the very first days of symptoms,4/26/2020
6,2020-03-27,Clinical and virological data of the first cases of COVID-19 in Europe,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30200-0/fulltext,The Lancet Infectious disease,Observational Cohort study,5.0,range: 30-80,Urine,N,N,High viral loads in upper respiratory tract samples are suggestive of potentially high risk of transmissibility during the very first days of symptoms,4/26/2020
7,2020-03-27,Clinical and virological data of the first cases of COVID-19 in Europe,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30200-0/fulltext,The Lancet Infectious disease,Observational Cohort study,5.0,range: 30-80,Stool,N,Y,High viral loads in upper respiratory tract samples are suggestive of potentially high risk of transmissibility during the very first days of symptoms,4/26/2020
8,2020-03-28,Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa345/5812997,Oxford Academic,Observational Cohort study,323.0,median: 40; range 32-63,Lower respirratory tract,N,Y,"The viral load in the early and progressive stages were significantly higher than that in the recovery stage, RT-PCR is sensitive and reliable, but ddPCR performed better in detecting low-viralload samples.",4/26/2020
9,2020-03-28,Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa345/5812997,Oxford Academic,Observational Cohort study,323.0,median: 40; range 32-63,Nasal,N,N,"The viral load in the early and progressive stages were significantly higher than that in the recovery stage, RT-PCR is sensitive and reliable, but ddPCR performed better in detecting low-viralload samples.",4/26/2020
10,2020-03-28,Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa345/5812997,Oxford Academic,Observational Cohort study,323.0,median: 40; range 32-63,Throat,N,N,"The viral load in the early and progressive stages were significantly higher than that in the recovery stage, RT-PCR is sensitive and reliable, but ddPCR performed better in detecting low-viralload samples.",4/26/2020
11,2020-03-28,Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa345/5812997,Oxford Academic,Observational Cohort study,323.0,median: 40; range 32-63,Sputum,N,Y,"The viral load in the early and progressive stages were significantly higher than that in the recovery stage, RT-PCR is sensitive and reliable, but ddPCR performed better in detecting low-viralload samples.",4/26/2020
12,2020-03-28,Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa345/5812997,Oxford Academic,Observational Cohort study,323.0,median: 40; range 32-63,Urine,N,N,"The viral load in the early and progressive stages were significantly higher than that in the recovery stage, RT-PCR is sensitive and reliable, but ddPCR performed better in detecting low-viralload samples.",4/26/2020
13,2020-03-28,Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa345/5812997,Oxford Academic,Observational Cohort study,323.0,median: 40; range 32-63,Blood,N,N,"The viral load in the early and progressive stages were significantly higher than that in the recovery stage, RT-PCR is sensitive and reliable, but ddPCR performed better in detecting low-viralload samples.",4/26/2020
14,2020-02-28,A Well Infant With Coronavirus Disease 2019 With High Viral Load,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa201/5766416,Oxford Academic,Case study,1.0,6 months,Nasopharyngeal,Y,Y,"Even in absence of clinical symptoms, high nasopharynx viral load was present on admission, and + stool sample on 9th day of admissison stayed postive for 16 days",4/26/2020
15,2020-02-28,A Well Infant With Coronavirus Disease 2019 With High Viral Load,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa201/5766416,Oxford Academic,Case study,1.0,6 months,Blood,Y,N,"Even in absence of clinical symptoms, high nasopharynx viral load was present on admission, and + stool sample on 9th day of admissison stayed postive for 16 days",4/26/2020
16,2020-02-28,A Well Infant With Coronavirus Disease 2019 With High Viral Load,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa201/5766416,Oxford Academic,Case study,1.0,6 months,Stool,Y,Y,"Even in absence of clinical symptoms, high nasopharynx viral load was present on admission, and + stool sample on 9th day of admissison stayed postive for 16 days",4/26/2020
17,2020-02-28,A Well Infant With Coronavirus Disease 2019 With High Viral Load,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa201/5766416,Oxford Academic,Case study,1.0,6 months,Urine,Y,N,"Even in absence of clinical symptoms, high nasopharynx viral load was present on admission, and + stool sample on 9th day of admissison stayed postive for 16 days",4/26/2020
18,2020-03-19,Understanding COVID-19: what does viral RNA load really mean?,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30237-1/fulltext,The New England Journal of Medicine,Observational Cohort study,17.0,median: 59;  range 26 - 76,Nasal,Y,Y,"The viral load that was detected in the asymptomatic patient was similar to that in the symptomatic patients, which suggests the transmission potential of asymptomatic or minimally symptomatic patients",4/26/2020
19,2020-03-19,Understanding COVID-19: what does viral RNA load really mean?,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30237-1/fulltext,The New England Journal of Medicine,Observational Cohort study,17.0,median: 59;  range 26 - 76,Throat,Y,N,"The viral load that was detected in the asymptomatic patient was similar to that in the symptomatic patients, which suggests the transmission potential of asymptomatic or minimally symptomatic patients",4/26/2020
20,2020-03-18,Temporal dynamics in viral shedding and transmissibility of COVID-19,https://www.medrxiv.org/content/10.1101/2020.03.15.20036707v2,medRxIV,Retrospective cohort study,94.0,median: 47,Throat,N,Y,viral shedding of laboratory-confirmed COVID-19 patients peaked on or before symptom onset,4/26/2020
21,2020-03-16,Duration of viral detection in throat and rectum of a patient with COVID-19,https://www.medrxiv.org/content/10.1101/2020.03.07.20032052v1,medRxIV,Case study,1.0,73,Urine,N,Y,"Despite clinical recovery, SARS-CoV-2 RNA remained detectable by real time RT21 PCR in throat and rectal swabs until day 11 and 18",4/26/2020
22,2020-03-16,Duration of viral detection in throat and rectum of a patient with COVID-19,https://www.medrxiv.org/content/10.1101/2020.03.07.20032052v1,medRxIV,Case study,1.0,73,Throat,N,N,"Despite clinical recovery, SARS-CoV-2 RNA remained detectable by real time RT21 PCR in throat and rectal swabs until day 11 and 18",4/26/2020
23,2020-03-16,Duration of viral detection in throat and rectum of a patient with COVID-19,https://www.medrxiv.org/content/10.1101/2020.03.07.20032052v1,medRxIV,Case study,1.0,73,Rectal,N,Y,"Despite clinical recovery, SARS-CoV-2 RNA remained detectable by real time RT21 PCR in throat and rectal swabs until day 11 and 18",4/26/2020
24,2020-03-08,Virological assessment of hospitalized cases of coronavirus disease 2019,https://www.medrxiv.org/content/10.1101/2020.03.05.20030502v1,medRxIV,Cohort study,7.0,middle-aged,Oro- and nasopharyngeal,N,Y,Diagnostic testing suggests that simple throat swabs will provide sufficient sensitivity at this stage of infection,4/26/2020
25,2020-03-08,Virological assessment of hospitalized cases of coronavirus disease 2019,https://www.medrxiv.org/content/10.1101/2020.03.05.20030502v1,medRxIV,Cohort study,7.0,middle-aged,Sputum,N,Y,Diagnostic testing suggests that simple throat swabs will provide sufficient sensitivity at this stage of infection,4/26/2020
26,2020-03-08,Virological assessment of hospitalized cases of coronavirus disease 2019,https://www.medrxiv.org/content/10.1101/2020.03.05.20030502v1,medRxIV,Cohort study,7.0,middle-aged,Stool,N,Y,Diagnostic testing suggests that simple throat swabs will provide sufficient sensitivity at this stage of infection,4/26/2020
27,2020-03-08,Virological assessment of hospitalized cases of coronavirus disease 2019,https://www.medrxiv.org/content/10.1101/2020.03.05.20030502v1,medRxIV,Cohort study,7.0,middle-aged,Blood,N,N,Diagnostic testing suggests that simple throat swabs will provide sufficient sensitivity at this stage of infection,4/26/2020
28,2020-03-08,Virological assessment of hospitalized cases of coronavirus disease 2019,https://www.medrxiv.org/content/10.1101/2020.03.05.20030502v1,medRxIV,Cohort study,7.0,middle-aged,Urine,N,N,Diagnostic testing suggests that simple throat swabs will provide sufficient sensitivity at this stage of infection,4/26/2020
29,2020-04-23,SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179376/,BMC- critical care,Retrospective study,92.0,mean: 55,Lower respiratory tract sputum,N,Y,Positive association between sputum viral load and disease severity as well as risk of progression.,5/9/2020
30,2020-03-07,Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19,https://www.ijidonline.com/article/S1201-9712(20)30141-7/pdf,International Journal of Infectious Disease,Retrospective study,51.0,median:35;  range: 24-65,Throat,N,Y,"COVID-19 can present as pneumonia with the onset of few symptoms, and the infectivity of SARS-CoV-2 may gradually decrease in patients",5/9/2020
31,2020-03-30,Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test,https://www.medrxiv.org/content/10.1101/2020.03.26.20044222v1,medRxIV,Retrospective study,262.0,range 14-60,Chest CT,N,N,diseases of redetected Positive patients did not progress into more severe status even if their RNA was detected to be positive for SARS-CoV-2.,5/9/2020
32,2020-03-23,Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study,https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30196-1.pdf,The Lancet Infectious disease,Observational Cohort study,23.0,median: 62; range: 37–75,Blood,N,N,"For most patients, the viral load of SARS-CoV-2 wasvery high at presentation and declined steadily. Despitedevelopment of antibodies against surface and internal proteins of SARS-CoV-2, viral RNA could still be detected in posterior oropharyngeal (deep throat) saliva samples",5/9/2020
33,2020-03-23,Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study,https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30196-1.pdf,The Lancet Infectious disease,Observational Cohort study,23.0,median: 62;  range: 37–75,Urine,N,N,"For most patients, the viral load of SARS-CoV-2 wasvery high at presentation and declined steadily. Despitedevelopment of antibodies against surface and internal proteins of SARS-CoV-2, viral RNA could still be detected in posterior oropharyngeal (deep throat) saliva samples",5/9/2020
34,2020-03-23,Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study,https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30196-1.pdf,The Lancet Infectious disease,Observational Cohort study,23.0,median: 62;  range: 37–75,Posterior oropharyngeal saliva,N,Y,"For most patients, the viral load of SARS-CoV-2 wasvery high at presentation and declined steadily. Despitedevelopment of antibodies against surface and internal proteins of SARS-CoV-2, viral RNA could still be detected in posterior oropharyngeal (deep throat) saliva samples",5/9/2020
35,2020-03-23,Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study,https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30196-1.pdf,The Lancet Infectious disease,Observational Cohort study,23.0,median: 62;  range: 37–75,Rectal,N,N,"For most patients, the viral load of SARS-CoV-2 wasvery high at presentation and declined steadily. Despitedevelopment of antibodies against surface and internal proteins of SARS-CoV-2, viral RNA could still be detected in posterior oropharyngeal (deep throat) saliva samples",5/9/2020
36,2020-04-17,Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa449/5821311,Clinical Infectious Disease,Clinical Study,48.0,mean:64.6;  range 48-81,Serum,N,Y,"serum SARS-CoV2 nucleic acid (RNAaemia) is only detectable in some patients. However, it is not clear under what circumstances it can be detected and whether the incidence of RNAaemia is related to certain types of patients",5/26/2020
37,2020-05-18,Highly sensitive and full-genome interrogation of SARS-CoV-2 using multiplexed PCR enrichment followed by next-generation sequencing,https://doi.org/10.1101/2020.03.12.988246,bioRxiv,Other,13.0,-,Nasopharyngeal,N,Y,we built a mathematical model to estimate the limit of detection (LOD) for SARS-CoV-2,6/10/2020
38,2020-05-15,Comparative Analysis of Early-Stage Clinical Features Between COVID-19 and Influenza A H1N1 Virus Pneumonia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243732/,Front Public Health,Retrospective study,15.0,median:52 ; range:30-78,Nasopharyngeal,N,Y,patients with COVID-19 are more likely to progress within 1 week and plain chest CT imaging is a very convenient means of monitoring the condition of the lung,6/10/2020
39,2020-02-24,Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea,https://synapse.koreamed.org/DOIx.php?id=10.3346/jkms.2020.35.e86,Journal of Korean Medicine,Case study,2.0,-,Upper respiratory tract; lower respiratory tract,N,Y,"However, it appeared that the viral loads already started to decrease from around day 7 in both URT and LRT specimens",6/10/2020
40,2020-04-17,Clinical Characteristics of Children with COVID-19: A Rapid Review and Meta-Analysis,https://doi.org/10.1101/2020.04.13.20064352,MedRxiv,Systematic review,1667.0,<18,sputum,Y,Y,"Children had on average milder symptoms, with many children having even no symptoms.",6/10/2020
41,2020-03-21,Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients,https://www.ncbi.nlm.nih.gov/pubmed/32209381/,J Infect,Retrospective cohort study,32.0,range: 34-54,nasal swab,Y,Y,"viral shedding time of SARS-CoV2 in ICU patients was longer than that of non-ICU patients, especially nasal swab samples",6/10/2020
42,2020-03-21,Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients,https://www.ncbi.nlm.nih.gov/pubmed/32209381/,J Infect,Retrospective cohort study,32.0,range: 34-54,blood,Y,Y,"viral shedding time of SARS-CoV2 in ICU patients was longer than that of non-ICU patients, especially nasal swab samples",6/10/2020
43,2020-03-21,Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients,https://www.ncbi.nlm.nih.gov/pubmed/32209381/,J Infect,Retrospective cohort study,32.0,range: 34-54,urine,Y,N,"viral shedding time of SARS-CoV2 in ICU patients was longer than that of non-ICU patients, especially nasal swab samples",6/10/2020
44,2020-03-21,Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients,https://www.ncbi.nlm.nih.gov/pubmed/32209381/,J Infect,Retrospective cohort study,32.0,range: 34-54,tears,Y,N,"viral shedding time of SARS-CoV2 in ICU patients was longer than that of non-ICU patients, especially nasal swab samples",6/10/2020
45,2020-03-30,"SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge",https://doi.org/10.1101/2020.03.24.20042689,MedRxiv,Other,39.0,-,pharyngeal,N,Y,We showed evidences that dPCR  is powerful in detecting asymptomatic patients and suspected patients,6/10/2020
46,2020-03-30,"SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge",https://doi.org/10.1101/2020.03.24.20042689,MedRxiv,Other,39.0,-,stool,N,N,We showed evidences that dPCR  is powerful in detecting asymptomatic patients and suspected patients,6/10/2020
47,2020-03-30,"SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge",https://doi.org/10.1101/2020.03.24.20042689,MedRxiv,Other,39.0,-,blood,N,Y,We showed evidences that dPCR  is powerful in detecting asymptomatic patients and suspected patients,6/10/2020
48,2020-05-18,A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients,https://www.sciencedirect.com/science/article/pii/S1286457920300861?v=s5,Microbes Infect,Other,238.0,median: 55,pharyngeal,N,Y,"After the 11th day post-disease onset, the diagnosis for viral infection should be majorly dependent on serological assay",6/10/2020
